Document Classification

Section Type: RESULTS

Text: There were no between-group differences in overall outcome scores (pantoprazole vs. ranitidine : S0 : 91. 2 vs. 89. 3 %, S1 : 1. 5 vs. 2. 5 %, S2 : 5. 4 vs. 5. 7 %, S3 : 1. 7 vs. 2. 1 %, S4 : 0. 19 vs. 0. 38 %, P = 0. 083), 72-h clinically detected rebleeding (2. 9 % [95 % CI 1. 7, 4. 6] vs. 3. 2 % [95 % CI 2. 0, 4. 9]), surgery (1. 9 % [95 % CI 1. 0, 3. 4] vs. 2. 1 % [95 % CI 1. 1, 3. 5]) or day-3 mortality (0. 2 % [95 % CI 0, 0. 09] vs. 0. 3 % [95 % CI 0, 1. 1]).